Epigenetic changes mediated by polycomb repressive complex 2 and E2a are associated with drug resistance in a mouse model of lymphoma-Reference-Cited by-同舟云学术

Epigenetic changes mediated by polycomb repressive complex 2 and E2a are associated with drug resistance in a mouse model of lymphoma

Published:2016-05-04 Issue:1 Volume:8 Page:
ISSN:1756-994X
Container-title:Genome Medicine
language:en
Short-container-title:Genome Med

Author:

Flinders Colin,Lam Larry,Rubbi Liudmilla,Ferrari Roberto,Fitz-Gibbon Sorel,Chen Pao-Yang,Thompson Michael,Christofk Heather,B Agus David,Ruderman Daniel,Mallick Parag,Pellegrini Matteo

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13073-016-0305-0.pdf

Reference49 articles.

1. Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13(10):714–26. doi: 10.1038/nrc3599 .

2. Weigert O, Weinstock DM. The evolving contribution of hematopoietic progenitor cells to lymphomagenesis. Blood. 2012;120(13):2553–61. doi: 10.1182/blood-2012-05-414995 .

3. Mumenthaler SM, Foo J, Leder K, Choi NC, Agus DB, Pao W, et al. Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer. Mol Pharm. 2011;8(6):2069–79. doi: 10.1021/mp200270v .

4. Choi MK, Jun HJ, Lee SY, Kim KH, do Lim H, Kim K, et al. Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea. Ann Hematol. 2009;88(11):1099–106. doi: 10.1007/s00277-009-0729-3 .

5. Richter-Larrea JA, Robles EF, Fresquet V, Beltran E, Rullan AJ, Agirre X, et al. Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma. Blood. 2010;116(14):2531–42. doi: 10.1182/blood-2010-02-268003 .

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radio-immunotherapy by 188Re-antiCD20 and stable silencing of IGF-IR in Raji cells, new insight in treatment of lymphoma;Gene;2023-10

2. Single‑cell multi‑omics advances in lymphoma research (Review);Oncology Reports;2023-08-23

3. Radio-immunotherapy by 188Re-antiCD20 and stable silencing of IGF-IR in Raji cells, new insight in treatment of lymphoma;2023-01-09

4. Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges;Frontiers in Pharmacology;2022-05-20

5. Stem Cell Theory of Cancer: Implications for Drug Resistance and Chemosensitivity in Cancer Care;Cancers;2022-03-18